-
Study aim
-
Control of pulmonary involvement in the initial stages of COVID-19 and before reaching severe degrees of ARDS
-
Design
-
The randomized, controlled clinical trial, phase 3, will be conducted on 30 hospitalized patients with SARS with acute hypoxia. For randomization, at first stage, 30 spheres from one to 30 are considered and following that will be randomly divided into two equal parts, including P (prone) and group S (supine), and then the ball of each group are taken out and the intended sequence will be recorded
-
Settings and conduct
-
Eligible patients admitted to COVID-19 ward at Kosar hospital, Semnan are assessed after being in the position of peron and supine and returne to normal position. After three days of receiving the oxygen by reserve bag, ABG, ESR, CRP, PaO2 and FiO2 are checked and compared in the two groups.
-
Participants/Inclusion and exclusion criteria
-
30 patients with acute hypoxia and hospitalized for SARS-CoV-2. Inclusion criterion included patients admitted to the ward with SARS-CoV-2 whose diagnosis was confirmed by PCR test and acute hypoxemia based on PaO2/FiO2 between 150-300 and age between 18 and 70 years old. Exclusion criterion included respiratory arrest or unstable cardiorespiratory condition, inability to protect the airways, apnea, intolerance of prone position. facial and oral trauma at the last 2 weeks, pulmonary embolism in the last two years, pregnancy and systemic diseases including asthma, chronic obstructive pulmonary disease, heart failure, unstable angina pectoris exclude from study.
-
Intervention groups
-
In intervention group, patients who need to continuous oxygen therapy by reserve bag will be placed in a prone position for one hour, every three hours up to three days. In control group, patients who need to continuous oxygen therapy by reserve bag will be placed in a supine position .
-
Main outcome variables
-
Arterial blood oxygen saturation level